Skip to main content
Livermore
Livermore
ZHEN

First Trust Advisors LP

SEC CIK
0001125816
Latest filing
Aug 11, 2026

CPRX holding history

Catalyst Pharmaceuticals, Inc. in every 13F filed by First Trust Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CPRX overviewAll 13F holders of CPRXFull Q2 2026 holdings

Shares (Q2 2026)
282,887
Value
$8.89M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of CPRX by First Trust Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026282,887$8.89M<0.1%−63,357−18.3%ReducedHolders
Q1 2026346,244$8.57M<0.1%+254,902+279.1%AddedHolders
Q4 202591,342$2.13M<0.1%−93,798−50.7%ReducedHolders
Q3 2025185,140$3.65M<0.1%−117,140−38.8%ReducedHolders
Q2 2025302,280$6.56M<0.1%+60,114+24.8%AddedHolders
Q1 2025242,166$5.87M<0.1%−1,991,668−89.2%ReducedHolders
Q4 20242,233,834$46.6M<0.1%−195,139−8.0%ReducedHolders
Q3 20242,428,973$48.3M<0.1%−43,960−1.8%ReducedHolders
Q2 20242,472,933$38.3M<0.1%+2,248,850+1,003.6%AddedHolders
Q1 2024224,083$3.57M<0.1%+124,238+124.4%AddedHolders
Q4 202399,845$1.68M<0.1%+5,476+5.8%AddedHolders
Q3 202394,369$1.10M<0.1%−69,974−42.6%ReducedHolders
Q2 2023164,343$2.21M<0.1%+164,343NewHolders
Q1 20230$00.0%−167,435−100.0%Sold outHolders
Q4 2022167,435$3.11M<0.1%+167,435NewHolders
Q3 20220$00.0%−142,629−100.0%Sold outHolders
Q2 2022142,629$1.00M<0.1%−4,402−3.0%ReducedHolders
Q1 2022147,031$1.22M<0.1%−8,535−5.5%ReducedHolders
Q4 2021155,566$1.05M<0.1%+19,408+14.3%AddedHolders
Q3 2021136,158$722.0K<0.1%−107,904−44.2%ReducedHolders
Q2 2021244,062$1.40M<0.1%−9,501−3.7%ReducedHolders
Q1 2021253,563$1.17M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.